By Dr Andrea Schaffer

Preprints

Andrews CD; Parker EPK; Horne E; Walker V; Palmer T; Schaffer AL; Green ACA; Curtis HJ; Walker AJ; Bridges L; Wood C; Speed V; Bates C; Cockburn J; Parry J; Mehrkar A; MacKenna B; Bacon SCJ; Goldacre B; Hernan MA; Sterne JAC; Hulme WJ, 2024, OpenSAFELY: Effectiveness of COVID-19 vaccination in children and adolescents, http://dx.doi.org/10.1101/2024.05.20.24306810

Nab L; Schaffer A; Hulme WJ; DeVito NJ; Dillingham I; Wiedemann M; Andews C; Curtis H; Fisher L; Green A; Massey J; Walters C; Higgins R; Cunningham C; Morley J; Mehrkar A; Hart L; Davy S; Evans D; Hickman G; Inglesby P; Morton CE; Smith RM; Ward T; O'Dwyer T; Maude S; Bridges L; Butler-Cole BFC; Stables CL; Stokes P; Bates C; Cockburn J; Hester F; Parry J; Bhaskaran K; Schultze A; Rentsch CT; Mathur R; Tomlinson L; Williamson E; Smeeth L; Walker A; Bacon S; MacKenna B; Goldacre B, 2024, OpenSAFELY: a platform for analysing electronic health records designed for reproducible research, http://dx.doi.org/10.31219/osf.io/hj2sg

Andrews C; Prestige E; Parker EPK; Walker V; Palmer T; Schaffer A; Green ACA; Curtis H; Walker A; Smith R; Wood C; Bates C; Mehrkar A; MacKenna B; Bacon SCJ; Goldacre B; Hernán M; Sterne JAC; the OpenSAFELY collaborative ; Hulme W, 2024, Comparative safety and effectiveness of Pfizer BA.4-5 versus Sanofi during the spring 2023 COVID-19 booster vaccination programme in England: a matched cohort study in OpenSAFELY-TPP, http://dx.doi.org/10.1101/2024.03.15.24304277

Cunningham C; Macdonald O; Schaffer A; Brown A; Wiedemann M; Higgins R; Bates C; Parry J; Fisher L; Curtis H; Mehrkar A; Hart L; Bacon S; Hulme W; Speed V; Ward T; Croker R; Wood C; Walker A; Andrews C; Butler-Cole B; Evans D; Inglesby P; Dillingham I; Davy S; Bridges L; O’Dwyer T; Maude S; Smith R; Goldacre B; MacKenna B, 2024, The impact of the COVID-19 pandemic on Antidepressant Prescribing with a focus on people with learning disability and autism: An interrupted time-series analysis in England using OpenSAFELY-TPP, http://dx.doi.org/10.1101/2024.05.08.24306990

Zoega H; Falster M; Gillies M; Litchfield M; Camacho X; Bruno C; Daniels B; Donnolley N; Havard A; Schaffer A; Chambers G; Degenhardt L; Dobbins T; Gisev N; Ivers R; Jorm L; Liu B; Vajdic C; Pearson S-A, 2024, The Medicines Intelligence Data Platform: A population-based data resource from New South Wales, Australia, http://dx.doi.org/10.1101/2024.04.29.24306520

Schaffer A; Hulme W; Horne E; Parker E; Walker V; Stables C; Mehrkar A; Bacon SCJ; Bates C; Goldacre B; Walker A; The OpenSAFELY Collaborative ; Hernán M; Sterne J, 2023, Effect of the 2022 COVID-19 booster vaccination campaign in 50 year olds in England: regression discontinuity analysis in OpenSAFELY, http://dx.doi.org/10.1101/2023.09.07.23295194

The OpenSAFELY collaborative ; Tazare J; Nab L; Zheng B; Hulme W; Green A; Curtis H; Mahalingasivam V; Higgins R; Schultze A; Bhaskaran K; Mehrkar A; Schaffer A; Smith R; Bates C; Cockburn J; Parry J; Hester F; Harper S; Eggo R; Walker A; Marks M; Brown M; Maringe C; Leyrat C; Evans S; Goldacre B; MacKenna B; Sterne J; Tomlinson L; Douglas I, 2023, Effectiveness of Sotrovimab and Molnupiravir in community settings in England across the Omicron BA.1 and BA.2 sublineages: emulated target trials using the OpenSAFELY platform, http://dx.doi.org/10.1101/2023.05.12.23289914

Schaffer A; Park R; Tazare J; Bhaskaran K; MacKenna B; Denaxas S; Denaxas S; Dillingham I; Bacon SCJ; Mehrkar A; Bates C; Goldacre B; Greaves F; Macleod J; The OpenSAFELY Collaborative ; National Core Studies Collaborative ; Tomlinson L; Walker A, 2023, Fit notes associated with COVID-19 in 24 million patients’ primary care records: A cohort study in OpenSAFELY-TPP, http://dx.doi.org/10.1101/2023.07.28.23293269

The OpenSAFELY Collaborative ; Brown A; Fisher L; Curtis H; Wiedemann M; Hulme W; Hopcroft LEM; Cunningham C; Speed V; Costello R; Galloway J; Russell M; Bechman K; Kurt Z; Croker R; Wood C; Walker A; Schaffer A; Bacon SCJ; Mehrkar A; Hickman G; Bates C; Cockburn J; Parry J; Hester F; Harper S; Goldacre B; MacKenna B, 2023, OpenSAFELY: The impact of COVID-19 on azathioprine, leflunomide, and methotrexate monitoring, and factors associated with change in monitoring rate, http://dx.doi.org/10.1101/2023.06.06.23290826

The OpenSAFELY Collaborative ; Wood C; Speed V; Fisher L; Curtis H; Schaffer A; Walker A; Croker R; Brown A; Cunningham C; Hulme W; Andrews C; Butler-Cole B; Evans D; Inglesby P; Dillingham I; Bacon SCJ; Davy S; Ward T; Hickman G; Bridges L; O’Dwyer T; Maude S; Smith R; Mehrkar A; Bates C; Cockburn J; Parry J; Hester F; Harper S; Goldacre B; MacKenna B, 2023, The impact of COVID-19 on medication reviews in English primary care. An OpenSAFELY-TPP analysis of 20 million adult electronic health records, http://dx.doi.org/10.1101/2023.07.31.23293419

de Oliveira Costa J; Gillies M; Schaffer A; Peiris D; Zoega H; Pearson S-A, 2021, Changes in antidepressant use in Australia: A nationwide analysis prior to and during the COVID-19 pandemic (2015-2021), http://dx.doi.org/10.1101/2021.11.24.21266837

Schaffer A; Henry D; Zoega H; Elliott J; Pearson S-A, 2021, Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID-19 pandemic in Australia, http://dx.doi.org/10.1101/2021.09.26.21264150

Schaffer AL; Andrews CD; Brown AD; Croker R; Hulme WJ; Nab L; Quinlan J; Speed V; Wood C; Wiedemann M; Massey J; Inglesby P; Bacon SC; Mehrkar A; Bates C; Goldacre B; Collaborative TO; Walker AJ; MacKenna B, Changes in opioid prescribing during the COVID-19 pandemic in England: cohort study of 20 million patients in OpenSAFELY-TPP, http://dx.doi.org/10.1101/2024.02.23.24303238

Back to profile page